CTOs on the Move

Shared Health Services

www.sharedhealthservices.com

 
Shared Health Services is a wound care management company that contracts with hospitals to help them open and manage successful outpatient wound care and hyperbaric centers. The mission of our Wound Care Centers is to heal chronic wounds, improve patient outcomes, help prevent limb loss and provide a profitable service for our contracted hospitals.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Walco International

Walco International, Inc. is a full line distributor serving the needs of the professional animal health community in both food and companion animal markets.

Kalispell Regional Medical Center

Kalispell Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Kalispell Regional Medical Center is based in Kalispell, MT. You can find more information on Kalispell Regional Medical Center at www.krmc.org

Windsor House Inc

Windsor House Inc is a Girard, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sun Nuclear Corporation

Sun Nuclear Corporation is a designer and manufacturer of radiation measurement instrumentation for the Medical and Environmental industries. Founded in 1984 as a provider of third-party repair and calibration service, Sun Nuclear has grown to become a

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.